What role does sugar play in Multiple Myeloma growth

Multiple MyelomaMay 18, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sugar and Multiple Myeloma: What the Evidence Shows

This is an important question, and I can help explain what we know about sugar's relationship to cancer cells, including myeloma cells.

How Cancer Cells Use Sugar Differently

According to integrative oncology experts, cancer cells have a unique relationship with glucose (sugar) that's fundamentally different from healthy cells. Here's the key difference:

Cancer cells preferentially break down glucose through a process called glycolysis to produce energy, rather than using the more efficient oxygen-based energy production that normal cells use. This metabolic difference is so characteristic of cancer that it's actually used in PET scans—doctors inject patients with radioactive glucose, and it concentrates in cancer cells because they consume sugar so rapidly.

As Dr. [removed] Abrams explains in the integrative cancer care literature: "Cancer needs sugar. It doesn't use oxygen." This is why high sugar consumption may create an environment that supports cancer cell growth.

What This Means for Myeloma Patients

While the NCCN Guidelines for Patients: Multiple Myeloma don't specifically detail sugar restriction as a primary treatment, the broader cancer metabolism research suggests:

  • High blood sugar levels trigger insulin and insulin-like growth factor responses, both of which promote inflammation—and inflammation can support cancer cell growth
  • Ultra-processed foods (which are high in added sugars) are associated with increased cancer risk according to World Cancer Research Fund guidelines
  • Avoiding sugary drinks is recommended as a cancer prevention strategy, particularly because liquid sugar bypasses the fiber that would normally slow sugar absorption

Important Distinctions

It's crucial to understand that:

  • Sugar doesn't directly "feed" myeloma cells in the way some popular claims suggest—cancer is more complex than that
  • Metabolic approaches are emerging research, not yet standard care according to NCCN Guidelines
  • Individual variation matters: Different myeloma cells may have different metabolic dependencies

Questions to Ask Your Myeloma Care Team

  1. Should I modify my sugar intake as part of my overall treatment plan? Your oncologist can advise based on your specific situation.
  2. Are there nutritional guidelines specific to my myeloma type and treatment? Different treatments may have different nutritional considerations.
  3. Should I work with an oncology nutritionist? They can help you optimize nutrition while managing treatment side effects.
  4. Are there any metabolic approaches being studied for my specific myeloma? Clinical trials may be available.

The Bottom Line

While reducing sugar intake is generally recommended for cancer patients as part of an anti-inflammatory, whole-foods approach, it's not a substitute for standard myeloma treatment. The NCCN Guidelines emphasize that multi-drug therapy, hematopoietic cell transplant, and other targeted treatments are the foundation of myeloma care.

Think of nutrition as part of creating an overall healthier internal environment—what one expert calls "making your soil as inhospitable as possible to the growth and spread of the weed"—but not as a replacement for your oncology team's treatment recommendations.


Sources cited:

  • NCCN Guidelines for Patients: Multiple Myeloma (2025)
  • Integrative Cancer Care guidelines (Donald Abrams, MD)
  • World Cancer Research Fund/American Institute for Cancer Research guidelines

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: